JP2011502147A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502147A5
JP2011502147A5 JP2010532037A JP2010532037A JP2011502147A5 JP 2011502147 A5 JP2011502147 A5 JP 2011502147A5 JP 2010532037 A JP2010532037 A JP 2010532037A JP 2010532037 A JP2010532037 A JP 2010532037A JP 2011502147 A5 JP2011502147 A5 JP 2011502147A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutical composition
base
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010532037A
Other languages
English (en)
Japanese (ja)
Other versions
JP5343082B2 (ja
JP2011502147A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012224 external-priority patent/WO2009058267A2/en
Publication of JP2011502147A publication Critical patent/JP2011502147A/ja
Publication of JP2011502147A5 publication Critical patent/JP2011502147A5/ja
Application granted granted Critical
Publication of JP5343082B2 publication Critical patent/JP5343082B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010532037A 2007-10-29 2008-10-28 ベンゾモルホリン誘導体および使用方法 Expired - Fee Related JP5343082B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94807P 2007-10-29 2007-10-29
US61/000,948 2007-10-29
PCT/US2008/012224 WO2009058267A2 (en) 2007-10-29 2008-10-28 Benzomorpholine derivatives and methods of use

Publications (3)

Publication Number Publication Date
JP2011502147A JP2011502147A (ja) 2011-01-20
JP2011502147A5 true JP2011502147A5 (enExample) 2011-09-22
JP5343082B2 JP5343082B2 (ja) 2013-11-13

Family

ID=40394086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532037A Expired - Fee Related JP5343082B2 (ja) 2007-10-29 2008-10-28 ベンゾモルホリン誘導体および使用方法

Country Status (8)

Country Link
US (1) US7795254B2 (enExample)
EP (1) EP2220078B1 (enExample)
JP (1) JP5343082B2 (enExample)
AU (1) AU2008319366B2 (enExample)
CA (1) CA2703257C (enExample)
ES (1) ES2417009T3 (enExample)
MX (1) MX2010004620A (enExample)
WO (1) WO2009058267A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684182A5 (de) 1991-10-15 1994-07-29 Escher Wyss Ag Rotationsdruckmaschine.
MX2012013331A (es) 2010-05-19 2013-02-01 Sandoz Ag Purificacion de posaconazol y de intermediarios de posaconazol.
BR112012029225B1 (pt) 2010-05-19 2020-10-27 Sandoz Ag processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
JP2013532131A (ja) * 2010-05-19 2013-08-15 サンド・アクチエンゲゼルシヤフト ポサコナゾール中間体の製造
US9493428B2 (en) 2011-06-16 2016-11-15 Sandoz Ag Process for the preparation of a chiral compound

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755332A (en) * 1971-07-01 1973-08-28 Ciba Geigy Corp Substituted 4 indazolaminoquinolines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
GB9323290D0 (en) * 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
WO1996023774A1 (en) 1995-01-31 1996-08-08 Zenyaku Kogyo Kabushiki Kaisha Thioquinoline derivatives
GB9505651D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
GB9505702D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd Fungicidal compounds
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
EP0860433B1 (en) * 1995-11-07 2002-07-03 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
DE69613211T2 (de) * 1995-11-14 2001-11-15 Pharmacia & Upjohn S.P.A., Mailand/Milano Aryl- und heteroaryl- purin- und pyridopyrimidin- derivate
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
DE19614718A1 (de) * 1996-04-15 1997-10-16 Hoechst Schering Agrevo Gmbh Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
ATE293102T1 (de) * 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung
DE69924500T2 (de) * 1998-08-21 2006-02-09 Parker Hughes Institute, St. Paul Chinazolinderivate
EE05708B1 (et) * 1999-02-10 2014-04-15 Astrazeneca Ab Kinasoliini derivaat angiogeneesi inhibiitorina ja selle kasutamine
US6258820B1 (en) * 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
KR20010110750A (ko) * 1999-04-12 2001-12-13 앤드류 앵뉴 인테그린 길항제로서의 치환된 비사이클릭 헤테로아릴화합물
WO2002030924A1 (en) * 2000-10-13 2002-04-18 Astrazeneca Ab Quinazoline derivatives with anti-tumour activity
CN1308310C (zh) * 2000-10-20 2007-04-04 卫材R&D管理有限公司 含氮芳环衍生物
KR100883731B1 (ko) * 2001-06-22 2009-02-12 기린 파마 가부시끼가이샤 간세포 증식 인자 수용체 자기 인산화를 저해하는 퀴놀린유도체 및 퀴나졸린 유도체 및 이들을 함유하는 의약 조성물
MXPA04004219A (es) * 2001-11-03 2004-09-10 Astrazeneca Ab Derivados de quinazolina como agentes antitumorales.
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
WO2003064413A1 (en) * 2002-02-01 2003-08-07 Astrazeneca Ab Quinazoline compounds
US7645878B2 (en) * 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
DE60329910D1 (de) * 2002-03-29 2009-12-17 Novartis Vaccines & Diagnostic Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
EP1548008A4 (en) * 2002-08-23 2008-08-06 Kirin Pharma Kk COMPOUND WITH TGF-BETA-HEMMENDER EFFECT AND THIS MEDICAL COMPOSITION CONTAINING
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
WO2004078114A2 (en) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
US7531553B2 (en) * 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
GB0310401D0 (en) * 2003-05-07 2003-06-11 Astrazeneca Ab Therapeutic agent
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
WO2005070891A2 (en) * 2004-01-23 2005-08-04 Amgen Inc Compounds and methods of use
JO2787B1 (en) * 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use

Similar Documents

Publication Publication Date Title
JP2013510120A5 (enExample)
JP2006524222A5 (enExample)
JP2008255122A5 (enExample)
JP2009143956A5 (enExample)
JP2012510502A5 (enExample)
JP2011529054A5 (enExample)
JP2009536660A5 (enExample)
JP2005053931A5 (enExample)
JP2008533007A5 (enExample)
JP2011502147A5 (enExample)
JP2008518890A5 (enExample)
JP2015501820A5 (enExample)
JP2014506907A5 (enExample)
JP2015535839A5 (enExample)
JP2013010790A5 (enExample)
JP2012512863A5 (enExample)
JP2010520214A5 (enExample)
JP2014505017A5 (enExample)
JP2019524752A5 (enExample)
JP2009040767A5 (enExample)
JP2013517320A5 (enExample)
JP2012532894A5 (enExample)
JP2006523626A5 (enExample)
JP2017503016A5 (enExample)
JP2006514956A5 (enExample)